Agilon Health, Inc. · NYSE:AGL

Agilon Health — Wolfe Research Healthcare Conference 2024

9 slides from Agilon Health's conference presentation, Nov 19, 2024

  1. Slide 1: Wolfe Investor Presentation

    Wolfe Investor Presentation November 19, 2024 Copyright © 2024 agilon health

  2. Slide 2: Disclaimers and Forward-Looking Statements

    Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the

  3. Slide 3: Key Takeaways

    Key Takeaways Strengthening the business for long-term success off strong and improving partner base Structural demand and business fundamentals strong despite macro headwinds Robust growth has been a near-term headwind, but expect long-term powerful as environment and market mix stabilizes Taking k

  4. Slide 4: Structural Factors Drive Long-Term Demand

    Structural Factors Drive Long-Term Demand 210K PCPs serving 60M seniors (74M by 2032) need a better business model Accelerating Health Burden Primary Care Capacity is Strained % of adults age 65+ with one or more chronic conditions ~10-20% Projected Shortage by 2030 85.6% 100% 56.0% 23.1% 50% 0% 1 c

  5. Slide 5: Pace of Growth in this Environment has Created Near-Term Challenges but Powerful Long-Term Opportunity

    Pace of Growth in this Environment has Created Near-Term Challenges but Powerful Long-Term Opportunity Existing Members New Members 525K • Added 292K members in 160K ‘23/’24, 56% of 365K membership 140K 225K • Average member 143K 82K 365K vintage roughly flat over 51K 3 years 225K 143K 92K • ‘23 cla

  6. Slide 6: Post Recent Exits, all Year 1+ Partnerships Producing Positive Medical Margin

    Post Recent Exits, all Year 1+ Partnerships Producing Positive Medical Margin Partnerships being exited were driving AEBITDA loss Year 1 partnerships MA Medical Margin performing above (2024E, $PMPM, Year 2+ mid- incurred) performers (room to further mature) Year 2+, Near Exiting, Low Year 2+, Mid Y

  7. Slide 7: Improving Outcomes and Lowering Healthcare Costs

    Improving Outcomes and Lowering Healthcare Costs • ACO Reach: $150mm in gross savings (13% gross savings %); $37mm savings to Medicare Trust Fund; beat national trend by ~300 bps • agilon was one of only three Standard ACO parent companies that drove meaningful results at scale • agilon 2023MY STARs

  8. Slide 8: Actions We Are Taking to Strengthen the Platform for Long-Term Success

    Actions We Are Taking to Strengthen the Platform for Long- Term Success Exiting 2 unprofitable partnerships Narrowing ‘25 exposure to Part D risk Rationalizing our payor footprint Increasing conservatism around new partners based on payor dynamics Copyright © 2024 agilon health. 8

  9. Slide 9: Cash Flow Expectations

    Cash Flow Expectations Anticipate current cash position and cash flow management levers allow us to manage through macro environment and take action to accelerate the path to profitability and break-even cash flow. $113 $35 Cash Flow Levers • Partnership exits $35 • Tighter working capital $399 mana

agilon health — Wolfe Research Healthcare Conference 2024 on 6ix